Journal of Hepatocellular Carcinoma

Dove Medical Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Hepatocellular Carcinoma is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,940 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Dove Medical Press
ISSN
2253-5969
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,940 USD
Articles in DOAJ
1016
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2014-08-01
Indexing
DOAJ
APC
3,940 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1016

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

1081

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

45

i10-index

341

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2014-08-01
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
83%
ORCID iDs in current deposits
77%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101674775
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
Show all subjects (50)
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Hepatitis B Virus Studies
  • Hepatitis B Virus Studies
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Organ Transplantation Techniques and Outcomes
  • Organ Transplantation Techniques and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease and Transplantation
  • Liver Disease and Transplantation
  • Immune cells in cancer
  • Immune cells in cancer
  • Liver physiology and pathology
  • Liver physiology and pathology
  • Cancer Research and Treatment
  • Cancer Research and Treatment
  • Hepatitis C virus research
  • Hepatitis C virus research
  • MRI in cancer diagnosis
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • MRI in cancer diagnosis
  • Intraperitoneal and Appendiceal Malignancies
  • Intraperitoneal and Appendiceal Malignancies
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Angiogenesis and VEGF in Cancer
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Angiogenesis and VEGF in Cancer
  • RNA modifications and cancer
  • Endoplasmic Reticulum Stress and Disease

Keywords (DOAJ)

  • hepatocellular carcinoma
  • cancer
  • liver cancer
  • hepatitis b virus

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: